Crossmark

Active surveillance for intermediate risk prostate cancer could be risky for the patient

Published Online: 2021-07-01

Published Print: 2022-04

Authors

Moretti, Kim https://orcid.org/0000-0002-6712-6551
License Information

Text and Data Mining valid from 2021-07-01

Version of Record valid from 2021-07-01
More Information

Article History

Received: 11 June 2021

Accepted: 12 June 2021

First Online: 1 July 2021

Declarations

:

: I declare there are no conflicts of interest and this manuscript did not involve Human Participants and/or Animals nor the need to obtain informed consent.

Document is current